Abstract: The invention relates to a cosmetic base complex that contains extracts from fruit and daily products. Said base complex is characterized by an aqueous gel base which contains an encapsulated extract from an aqueous extraction of pineapple and the residue of an aqueous extraction of yogurt. The extractions are carried out in a temperature range of from 10 to 30° C. and the ratio of pineapple extract to yogurt residue ranges from 20:80 to 80:20. When used in a cosmetic preparation, the inventive complex may produce a certain feeling of happiness by increasing the serotonin and noradrenaline levels.

Abstract: The present invention relates to a fermented herbal health drink, comprising extract from plant Andrographis, extract from barley, wheat, and/or fruit and ethanol concentration ranging between 3 to 13% in the total health drink and optionally extract from plant Tinospora and other additives, said drink not containing hops and still having characteristic taste of a beer with no adverse effect and contributing to several medicinal properties comprising anti-oxidant, nervine relaxant, cholerectic, cardio-tonic, diurectic, digestive and immunomodulant, and a method of producing the herbal health drink, preferably a method of introducing bitterness into said health drink and using the same as a beer or to produce beer with said medicinal properties.

Abstract: The present invention is a fungicidal solution and method for controlling fungal disease in plants which provides for contacting the plant matter with a fungicidally effective application of an aqueous solution. The fungicidal solution is comprised of between about one-third (⅓) to two-third (⅔) cup of an organic plant matter to every two-third (⅔) gallon of a fermented solution. The organic solution may be any type of sage, tea leaves, coffee leaves, beech leaves, eucalyptus leaves, oak leaves, sumac leaves, and other similar leaves, or bark. The fermented solution contains between about (1%) one percent to (25%) twenty-five percent, per gallon, of an alcohol and grape juice.

Abstract: This invention provides a composition comprising extracts from the husk of Wenguanguo and a process of producing the combined extract comprising the following steps: extracting Wenguanguo husks with an organic solvent to form an organic extract; removing the organic solvent from the extract to form aqueous extracts; and drying and sterilizing the aqueous extracts to form the combined extracts. The extracts can be used to make medicines or health foods for preventing cerebral aging, improving memory, improving cerebral functions and curing enuresis, frequent micturition, urinary incontinence, dementia, weak intelligence and Alzheimer's disease and other diseases caused by cerebral dysfunction. The combined extracts contain saponin, saccharides, proteins and others.

Abstract: The present invention features a novel use of processed ingredients from the Indian mulberry plant, and particularly a novel use of one or more processed Morinda citrifolia-based naturaceutical formulations comprising one or more of a processed Morinda citrifolia fruit juice, puree juice, oil or oil extract, dietary fiber, alcohol extract, etc., for inhibiting and preventing the overgrowth of Candida fungus and for treating Candidiasis and its associated symptoms.

Abstract: This invention relates to compositions containing polyphenols, for example, cocoa polyphenols such as procyanidins, in combination with at least one cholesterol lowering agent, and methods for improving vascular health including treating and preventing atherosclerosis and cardiovascular disease.

Abstract: The present invention features a method for inhibiting, reducing, and/or preventing mutagenesis, or inducing antimutagenesis activity, through the prophylactic administration of a naturaceutical formulation comprising at least one of a processed Morinda citrifolia product. The present invention seeks to provide a natural composition, or naturaceutical, for the purpose of inhibiting both naturally occurring or spontaneous mutagenesis, as well as environmentally induced mutagenesis, within the body of a mammal.

Abstract: The invention herein relates to a topical liquid composition for promoting hair growth, comprising natural ingredients with no side-effects, which is effective in promoting hair growth and preventing hair loss. More particularly, the invention relates to the topical liquid composition for promoting hair growth, comprising the extracts which are formed by immersing the mixture of powders of Pinelliae Rhizoma, Caryophylli Flos, Rubi Fructus, Zanthoxyli Fructus, Viticis Fructus, Salviae Radix, and Thujae Semen in oil and ethanol, respectively, followed by aging for a fixed period of time.

Abstract: The present invention provides an antiallergic agent comprising, as an active ingredient, at least one of a tomato extract, tomato pericarp, naringenin chalcone or its derivatives, tricaffeoylquinic acid or its derivatives and dicaffeoylsuccinylquinic acid or its derivatives; a histamine-release inhibitor or a leukotriene-release inhibitor; and a medicament, food, drink or cosmetic comprising the antiallergic agent, the histamine-release inhibitor or the leukotriene-release inhibitor mentioned above; and a method for producing an antiallergic agent comprising extracting raw material tomato with a solvent.

Abstract: The present invention features a unique, natural formulation and method of administering the same to treat and prevent diabetes, or rather advances treatment of diabetes, by providing a naturaceutical composition or treatment formulated with one or more processed Morinda citrifolia products as derived from the Indian Mulberry plant. The Morinda citrifolia is particularly adapted to treat Type II diabetes. The Morinda citrifolia product is preferably a leaf extract, but may also be in the form of a juice, a puree juice, a dietary fiber, or other similar forms and is incorporated into various carriers or naturaceutical compositions suitable for in vivo treatment of a patient. The naturaceutical may also combine other food products into the naturaceutical, such as fruit juices, dietary supplements, vitamins and minerals, and others.

Abstract: The present invention relates to a fermented herbal health drink, comprising extract from plant Andrographis, extract from barley, wheat, and/or fruit and ethanol concentration ranging between 3 to 13% in the total health drink and optionally extract from plant Tinospora and other additives, said drink not containing hops and still having characteristic taste of a beer with no adverse effect and contributing to several medicinal properties comprising anti-oxidant, nervine relaxant, cholerectic, cardio-tonic, diurectic, digestive and immunomodulant, and a method of producing the herbal health drink, preferably a method of introducing bitterness into said health drink and using the same as a beer or to produce beer with said medicinal properties.

Abstract: A composition and method for stabilizing proanthocyanidin, especially for preventing, for example, its discoloration by oxidative polymerization. The method utilizes (and the composition contains) proanthocyanidin, and an amino acid having a hydroxyl group or a dipeptide containing said amino acid. Also shown is a drink, food, cosmetic or medicament which contains the composition.

Abstract: This invention relates to a pharmaceutical composition used for treating cardiovascular diseases and a method for preparing it. The pharmaceutical composition mainly contains polysacchrides, saponins and amino acids extracted from Radix ginseng, Radix ophiopogonis and Fructus schisandrae chinensis. The method of preparing it includes the following steps: Radix ginseng, Radix ophiopogonis and Fructus schisandrae chinensis are decocted together in water; water extract or eluate is precipitated with alcohol or acetone, treated with macroporous adsorption resin and with ion exchange resin, and then separated to obtain pharmaceutical composition containing effective fractions of polysacchrides, saponins and amino acids. The above mentioned pharmaceutical composition can be formed into various preparations by mixing with any pharmaceutically acceptable auxiliary materials.

Abstract: A composition including an aliquot of the herb Herba Epimedii; and an aliquot of at least three supplemental herbs selected from the group consisting of Fructus Rosae Laevigatae; Fructus Rubi; Fructus Psoralea; Radix Morindae Officinalis; Fructus Schisandrac Chinensis; Fructus Ligustri Lucidi; Semen Cuscutae; and Radix Astragali. A composition including icariin; ursolic acid; ellagic acid; psoralen; deoxyschizandrin; oleanolic acid; quercetin; aslvagaloside; and an extract of the herb Radix Morindae Officinalis. Methods including administering a composition directed at treatment of various kidney disorders or the promotion of kidney health and to the overall health of the kidney, including the use of a composition in the treatment of prostate cancer, prophylatic prostate health, reduction of polyuria, incontinence, proteinuria, as well as for sexual satisfaction.

Abstract: The present invention features methods and formulations or compositions for the treatment of colon cancer, and particularly for the inhibition, prevention and/or reduction of cancerous cell growth, as well as the destruction of early stage cancerous cells within the colon region of a mammal, wherein the formulations and compositions comprise an identified amount or concentration of a processed Morinda citrifolia product or an active ingredient there from, as obtained from the Indian Mulberry plant.

Abstract: The present invention relates to an external agent for the skin comprising at least one member selected from the group consisting of maslinic acid, erythrodiol, uvaol, betulinic acid, betulin, physiologically acceptable salts thereof and derivatives thereof

Abstract: The present invention advances prior art intensive repair serums by providing an intensive repair serum formulated with Morinda citrifolia from the Indian Mulberry plant. The addition of Morinda citrifolia to the serum of the present invention serves to provide significant skin care advantages not found in prior art intensive repair serums.

Abstract: A medicinal composition has been created that is useful in the treatment of PMS in human females who experience adverse PMS symptoms. The composition is comprised of an extract of asparagus racemosus. The composition preferably includes about eighty-five parts Asparagus racemosus and about five parts each of Withania sominifera, Pedalium murex, and Tinospora cordifolia. The active component of the Asparagus racemosus is saponin glucoside (A4). Preferably, the composition is administered in capsular form with each capsule containing about one-half gram of the composition. Two of these capsules are taken three times a day.

Abstract: The present invention relates to an &agr;-amylase activity inhibitor containing, as an effective component, polyphenols obtained through the following process: guava leaves and/or guava fruit are subjected to extraction with one or more solvents selected from among water and hydrophilic solvents; the resultant extract is subjected to ultrafiltration, to thereby remove substances having a molecular weight of less than 5,000; the remaining fraction is subjected to the butyl support hydrophobic chromatography. The elution (flow rate: 1 mL/min) of the sample was accomplished with the pH gradient by use of sodium dihydrogenphosphate and sodium phosphate solution (0.02 mol/L) and a fraction of the eluted substance is recovered, which fraction corresponds to the third single peak of an elution curve which is obtained when the absorbance of the substance is measured at 260 nm.

Abstract: The present invention relates to the use of Phyllanthus for preventing or treating connective tissue proliferations, for maintaining the level of reduced glutathione, for inhibiting lipopolysaccharide (LPS)-induced nitric oxide synthase (NOS) and for inhibiting expression of the cyclooxygenase (COX-2) protein.

Abstract: A therapeutic composition for treating diabetes includes mixing of the following ingredients:

Abstract: A liquid dietary supplement useful in increasing bodily levels of coenzyme Q10 is disclosed. The supplement comprises an oil in water emulsion of coenzyme Q10. The dietary supplement disclosed is pleasant tasting, is effectively absorbed into the body and is believed to provide substantial therapeutic effects.

Abstract: The invention herein relates to a topical liquid composition for promoting hair growth, comprising natural ingredients with no side-effects, which is effective in promoting hair growth and preventing hair loss. More particularly, the invention relates to the topical liquid composition for promoting hair growth, comprising the extracts which are formed by immersing the mixture of powders of Pinelliae Rhizoma, Caryophylli Flos, Rubi Fructus, Zanthoxyli Fructus, Viticis Fructus, Salviae Radix, and Thujae Semen in oil and ethanol, respectively, followed by aging for a fixed period of time.

Abstract: The invention relates to extracts from residues left in the production of wine, and to the use thereof as active substance combinations for producing cosmetic and/or pharmaceutical compositions.

Abstract: A cranberry based dietary supplement or dental hygiene product is revealed with enhanced flavor characteristics. Cranberry sources are combined with extracts of the fruit of Lou Han Kuo and/or extracts from the leaves of Stevia rebaudiana and/or extracts from the leaves of Chinese Blackberry. The resulting product is a pleasant tasting dietary supplement, which is easily absorbed by the body in liquid form, and provides substantially therapeutic effects.

Abstract: A composition including an aliquot of the herb Herba Epimedii; and an aliquot of at least three supplemental herbs selected from the group consisting of Fructus Rosae laevigatae; Fructus Rubi; Fructus Psoralea; Radix Morindae officinalis; Fructus Schisandrac chinensis; Fructus Ligustri lucidi; Semen Cuscutae; and Radix Astragali. A composition including icariin; ursolic acid; ellagic acid; psoralen; deoxyschizandrin; oleanolic acid; quercetin; aslvagaloside; and an extract of the herb Radix Morindae Officinalis. Methods including administering a composition directed at treatment of various kidney disorders or the promotion of kidney health and to the overall health of the kidney, including the use of a composition in the treatment of prostate cancer, prophylatic prostate health, reduction of polyuria, incontinence, proteinuria, as well as for sexual satisfaction.

Abstract: The present invention features methods and formulations or compositions, such as a naturaceutical formulation, for treating and preventing headaches, and particularly migraine headaches, as well as methods and formulations for treating the conditions and symptoms often associated with migraine headaches. The naturaceutical formulations comprise an identified amount of a processed Morinda citrifolia product by weight, and the method comprises the prophylactic administration of the processed Morinda citrifolia product-based naturaceutical formulation in a safe, pre-determined or identified amount for a safe, pre-determined frequency, for a safe, pre-determined duration of time.

Abstract: The invention relates to the herbal composition which consists of: Centaurii umbellatum, Gentianaceae (centaury plant), Teraxacum officinale, Asteraceae (dandelion root), Juniperi communis L, Cupresaceae (juniper berry), Urticae dioica L, Urticeae (nettle plant), Urticae dioica L, Urticaceae (nettle root), Cichorium intybus L, Cichoriaceae (chicory root), Morus nigra L, Moraceae, (mulberry leaf), Achilleae millefolium L, Asteraceae (yarrow flower), Vaccinium myrtillus L, Ericaceae (bilberry leaf), Phaseolus vulgaris L, Fabaceae (bean pods), Valeriana officinalis L, Valerlanaceae (Valerian root).

Abstract: Disclosed is a method of preparing an extract of the herb sea buckthorn. In the absence of oxygen and metals berries of sea buckthorn are mixed with a vegetable oil and the mixture is incubated, which results in the extraction of liposoluble components of the berries into the vegetable oil. The extract is then separated from the berries. A composition is prepared of about 5 to about 95 wt % of the extract, 0 to about 95 wt % of an extract of a herb selected from the group consisting of rose hips (Rosa species), St. John's wort (Hypericus perforatum), chickweed herb (Stellaria media), plantain herb (Plantago major), calendula flowers (Calendula officinalis), and mixtures thereof, prepared by extracting liposoluble components of the herb into a vegetable oil in the absence of oxygen and metal, 0 to about 10 wt % of an essential oil, 0 to about 15 wt % of an antioxidant, and 0 to about 80 wt % of a diluent. The composition is applied to open skin lesions to promote their healing.

Abstract: Methods are provided for eliciting a beneficial health effect in a human or non-human animal which include adding at least one bixin compound or an extract of the annatto (Bixa orellana) seed to an animal feed, food product or nutritional supplement in an amount effective to increase the concentration of bixin in the blood supply of the animal when the food or supplement is consumed at a recommended daily dosage (unit dosage) for a sufficient number of days. A method of eliciting a therapeutic health effect in a human or non-human animal by adding an effective amount of at least one bixin compound to a pharmaceutical compound is also provided. The beneficial or therapeutic health effect may be further enhanced by the addition of at least one carotenoid compound or carotenoid-containing extract to the feed, food product, nutritional supplement, or pharmaceutical composition.

Abstract: This invention provides a method for identifying a composition of Cinnamomi and Poria. This invention further provides a composition comprising: Ramulus Cinnamomi, Poria Cortex, Moutan Radicis, Radix Paeonize Alba, and Semen Persicae. This invention provides various uses of these compositions.

Abstract: The present invention discloses: (i) a non-pathogenic probiotic microorganism and its probiotic/therapeutic uses; (ii) a formulation comprising an aqueous solution of a volatile fraction (VF) prepared from the extract of at least one plant derived material and its therapeutic uses; (iii) a process of manufacturing the formulation from the plant derived material; (iv) a probiotic composition comprising the non-pathogenic probiotic microorganism of the invention and/or other probiotic microorganism(s) and the formulation of the invention, and its probiotic/therapeutic uses; (v) a composition for industrial applications comprising the formulation of the invention and microorganism(s) of industrial applicability; and (vi) industrial processes and apparatuses in which the latter composition is used.

Abstract: The present invention provides a method as well as a composition for treating disorders of gastrointestinal tract and more specifically, for treating colon cancer. Method of treatment comprises the steps of administering to the human with colon cancer a composition comprising proteins-rich, lipids-rich and carbohydrates-rich food types. The method involves the use of forward flux of tissues growth factors and finds use in tissues cultures, animals and plants.

Abstract: The present invention provides a pharmaceutical composition for treating patients with HIV infection. The pharmaceutical composition is in the form of an intravenous injection solution and optionally capsules. The pharmaceutical composition contains fourteen (14) ingredients, i.e., diffuse hedyotis, bistort rhizome, giant knotweed rhizome, Asiatic moonseed rhizome, baical skullcap root, bovine biliary powder, milkvetch root, barbary wolfberry fruit, sanqi, figwort root, Chinese magnoliavine fruit, turmeric root-tuber, hawthorn fruit, and Chinese angelica.

Abstract: This invention provides a composition comprising extracts from the husk of Wenguanguo and a process of producing the combined extract comprising the following steps: extracting Wenguanguo husks with an organic solvent to form an organic extract; removing the organic solvent from the extract to form aqueous extracts; and drying and sterilizing the aqueous extracts to form the combined extracts. The extracts can be used to make medicines or health foods for preventing cerebral aging, improving memory, improving cerebral functions and curing enuresis, frequent micturition, urinary incontinence, dementia, weak intelligence and Alzheimer's disease and other diseases caused by cerebral dysfunction. The combined extracts contain saponin, saccharides, proteins and others.

Abstract: Tomato oleoresin is used in the prevention of LDL oxidation. Furthermore, the preparation of a pharmaceutical and a dietary composition for arresting the progression of atherosclerosis is described.

Abstract: There is disclosed a method for preventing CCL4 (carbon tetracloride) induced liver damage comprising the prophylactic administration of extracts of Morinda citrifolia. The Morinda citrifolia may be administered in solid or liquid forms. Several regimens are disclosed including the administration of 2 ounces twice daily in a liquid form such as that sold by Morinda, Inc.

Abstract: An herbal formulation comprises a liquid component and a solid component. The liquid component comprises oregano leaf, orange peel, Oregon grape root, pau d' arco, cinnamon bark, clove bud, and peppermint leaf. The solid component comprises uva ursi, garlic bulb, magnesium caprylate, citricidal extract, pau d' arco, calcium undecylenate, barberry root, neem leaf, olive leaf, and berberine sulphate.

Abstract: A medicinal preparation includes a number of medicinal materials having asari radix, fructus cnidii, nelumbo nucifera gaertner, ginseng radix, angelica sinensis radix, scutellaria baicalensis, phellodendron amurense radix, evodiae fructus, and saussureae radix, and grounded into powder, and blended with water to form a pasty material which may be refrigerated and dried to form a crystallized material. A number of substrates may then be mixed with the pasty material or the crystallized material, and rotated to form a gluey material for being used by the users.

Abstract: The present invention discloses: (i) a non-pathogenic probiotic microorganism and its probiotic/therapeutic uses; (ii) a formulation comprising an aqueous solution of a volatile fraction (VF) prepared from the extract of at least one plant derived material and its therapeutic uses; (iii) a process of manufacturing the formulation from the plant derived material; (iv) a probiotic composition comprising the non-pathogenic probiotic microorganism of the invention and/or other probiotic microorganism(s) and the formulation of the invention, and its probiotic/therapeutic uses; (v) a composition for industrial applications comprising the formulation of the invention and microorganism(s) of industrial applicability; and (vi) industrial processes and apparatuses in which the latter composition is used.

Abstract: The present invention discloses: (i) a non-pathogenic probiotic microorganism and its probiotic/therapeutic uses; (ii) a formulation comprising an aqueous solution of a volatile fraction (VF) prepared from the extract of at least one plant derived material and its therapeutic uses; (iii) a process of manufacturing the formulation from the plant derived material; (iv) a probiotic composition comprising the non-pathogenic probiotic microorganism of the invention and/or other probiotic microorganism(s) and the formulation of the invention, and its probiotic/therapeutic uses; (v) a composition for industrial applications comprising the formulation of the invention and microorganism(s) of industrial applicability; and (vi) industrial processes and apparatuses in which the latter composition is used.

Abstract: A new method is described for the treatment of cancer. The method utilizes two main parts. The first part is Soma, a healing herb described in the Rig Veda, the sacred scriptures of the Hindus. The second part is a composite of plant-derived substances and a mineral. When they are administered to cancer patients following the recommended therapeutic regimen, regression of the cancer results.

Abstract: A pharmaceutical composition suitable for the treatment of a condition selected from the group consisting of atherosclerosis, post-angioplasty restenosis, coronary artery disease, angina, small artery disease and other diseases caused by or are the result of hypercholesterolemia, or combination thereof comprising of a specific botanical plant. Specifically, the present invention relates to compositions comprising the herb or botanical Zizyphus jujube or extract thereof, which is useful in treating cardiovascular disorders, particularly those associated with elevated LDL and overall serum cholesterol levels. A method of preparing the pharmaceutical compositions of the invention and a method for treating a patient therewith are also disclosed.

Abstract: This invention provides compositions for repelling insects, particularly biting insects, such as mosquitoes, ticks, and biting flies comprising ratite oil, active fractions of ratite oil obtained by flash chromatography or compositions comprising mixtures of fatty acids found in ratite oil. Also provided are compositions for repelling insects comprising ratite oil, active fractions of ratite oil or compositions comprising mixtures of fatty acids found in ratite oil further comprising at least one additional insect repellent. Methods of repelling insects, particularly biting insects, are provided comprising topically applying ratite oil, active fractions of ratite oil, or compositions comprising mixtures of fatty acids found in ratite oil; or ratite oil, active fractions thereof, or compositions comprising fatty acids found in ratite oil and further comprising at least one additional insect repellent.

Abstract: The present invention provides a Vitex agnus castus extract wherein the extract is obtained by extracting dried and pulverized fruits of the plant Vitex agnus castus with a 90-100% ethanol solvent, separating the extraction solution from the rest of the plant material, removing the solvent from the extraction solution and recovering the extract. The present invention also provides for a dietary supplement comprising a Vitex agnus castus extract having a linoleic acid content of at least ten weight percent by the composition and a calcium source and the use of the extract and dietary supplement to treat conditions particularly affecting women.

Abstract: Compositions and methods are provided for reducing oxysterol buildup in the blood and normalizing cholesterol and blood pressure, in a mammal. The compositions comprise Morinda citrifolia extract, red wine extract, prune extract, blueberry extract, pomegranate extract, apple extract, and an enzyme mixture.

Abstract: This invention relates to a pharmaceutical composition comprising Platycodi Radix, Scutellariae Radix, Ponciri Fructus, Schizonepetae Herba, Bupleuri Radix, Angelicae dahuricae Radix, Paeoniae Radix alba, Cnidii Rhizoma, Angelicae gigantis Radix, Ledebouriellae Radix, Forsythiae Fructus, Glycyrrhizae Radix, Lonicerae Flos, Taraxaci Herba, Trichosanthis Radix, Ulmi Cortex Radicis, Astragali Radix, Atractylodis Rhizoma alba, Rehmanniae Rhizoma, Zanthoxyli Fructus, Magnoliae Flos, Xanthii Fructus, Mori Cortex Radicis, Pinelliae Tuber, Cimicifugae Rhizoma, Puerariae Radix and Menthae Herba as the active ingredients for preventing and/or treating acute and/or chronic allergic nasal diseases (including chronic paranasal sinusitis), allergic dermatitis, allergic otitis media (including recurrent otitis media with effusions), allergic conjunctivitis, allergic asthma, etc., and to a method for preparation thereof.

Abstract: The present invention discloses: (i) a non-pathogenic probiotic microorganism and its probiotic/therapeutic uses; (ii) a formulation comprising an aqueous solution of a volatile fraction (VF) prepared from the extract of at least one plant derived material and its therapeutic uses; (iii) a process of manufacturing the formulation from the plant derived material; (iv) a probiotic composition comprising the non-pathogenic probiotic microorganism of the invention and/or other probiotic microorganism(s) and the formulation of the invention, and its probiotic/therapeutic uses; (v) a composition for industrial applications comprising the formulation of the invention and microorganism(s) of industrial applicability; and (vi) industrial processes and apparatuses in which the latter composition is used.

Abstract: Compositions and methods for treating and preventing cancer are provided based on administration of a highbush blueberry extract.

Abstract: Disclosed is an anti-fatigue and nutritious tonic agent containing powder of wild ginseng, optionally in admixture with a herb medicine, or water extract of the powder, which has remarkably enhanced anti-fatigue, and nutrition and tonic effects as compared with agents containing cultivated ginseng.